816 related articles for article (PubMed ID: 30355944)
61. Exosomal Mst1 transfer from cardiac microvascular endothelial cells to cardiomyocytes deteriorates diabetic cardiomyopathy.
Hu J; Wang S; Xiong Z; Cheng Z; Yang Z; Lin J; Wang T; Feng X; Gao E; Wang H; Sun D
Biochim Biophys Acta Mol Basis Dis; 2018 Nov; 1864(11):3639-3649. PubMed ID: 30251683
[TBL] [Abstract][Full Text] [Related]
62. Sirtuin 3 deficiency exacerbates diabetic cardiomyopathy via necroptosis enhancement and NLRP3 activation.
Song S; Ding Y; Dai GL; Zhang Y; Xu MT; Shen JR; Chen TT; Chen Y; Meng GL
Acta Pharmacol Sin; 2021 Feb; 42(2):230-241. PubMed ID: 32770173
[TBL] [Abstract][Full Text] [Related]
63. Long Noncoding RNA OIP5-AS1 Overexpression Promotes Viability and Inhibits High Glucose-Induced Oxidative Stress of Cardiomyocytes by Targeting MicroRNA-34a/SIRT1 Axis in Diabetic Cardiomyopathy.
Sun H; Wang C; Zhou Y; Cheng X
Endocr Metab Immune Disord Drug Targets; 2021; 21(11):2017-2027. PubMed ID: 33380310
[TBL] [Abstract][Full Text] [Related]
64. Attenuation of ROS/Chloride Efflux-Mediated NLRP3 Inflammasome Activation Contributes to Alleviation of Diabetic Cardiomyopathy in Rats after Sleeve Gastrectomy.
Li S; Dong S; Shi B; Xu Q; Li L; Wang S; Zhang W; Zhong M; Zhu J; Cheng Y; Zhang G; Hu S
Oxid Med Cell Longev; 2022; 2022():4608914. PubMed ID: 35498125
[TBL] [Abstract][Full Text] [Related]
65. A Novel Circular RNA Mediates Pyroptosis of Diabetic Cardiomyopathy by Functioning as a Competing Endogenous RNA.
Yang F; Li A; Qin Y; Che H; Wang Y; Lv J; Li Y; Li H; Yue E; Ding X; Yu Y; Bai Y; Wang L
Mol Ther Nucleic Acids; 2019 Sep; 17():636-643. PubMed ID: 31400606
[TBL] [Abstract][Full Text] [Related]
66. Diazoxide preconditioning of endothelial progenitor cells from streptozotocin-induced type 1 diabetic rats improves their ability to repair diabetic cardiomyopathy.
Ali M; Mehmood A; Anjum MS; Tarrar MN; Khan SN; Riazuddin S
Mol Cell Biochem; 2015 Dec; 410(1-2):267-79. PubMed ID: 26359087
[TBL] [Abstract][Full Text] [Related]
67. LncRNA XIST shuttled by adipose tissue-derived mesenchymal stem cell-derived extracellular vesicles suppresses myocardial pyroptosis in atrial fibrillation by disrupting miR-214-3p-mediated Arl2 inhibition.
Yan B; Liu T; Yao C; Liu X; Du Q; Pan L
Lab Invest; 2021 Nov; 101(11):1427-1438. PubMed ID: 34389797
[TBL] [Abstract][Full Text] [Related]
68. [Impact and related mechanism on the improvement of hyperglycemia-induced pyroptosis in H9c2 cells by mircoRNA-214].
Wang Y; Zhao RZ; Chen PK; Xu GX; Liu ZJ; Long XP; Qiu ZM; Shi B
Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Oct; 47(10):820-828. PubMed ID: 31648465
[No Abstract] [Full Text] [Related]
69. Klotho protects the heart from hyperglycemia-induced injury by inactivating ROS and NF-κB-mediated inflammation both in vitro and in vivo.
Guo Y; Zhuang X; Huang Z; Zou J; Yang D; Hu X; Du Z; Wang L; Liao X
Biochim Biophys Acta Mol Basis Dis; 2018 Jan; 1864(1):238-251. PubMed ID: 28982613
[TBL] [Abstract][Full Text] [Related]
70. Knockdown of miR-372-3p Inhibits the Development of Diabetic Cardiomyopathy by Accelerating Angiogenesis via Activating the PI3K/AKT/mTOR/HIF-1
Han Z; Zhao D; Han M; Zhang R; Hao Y
Oxid Med Cell Longev; 2022; 2022():4342755. PubMed ID: 36160704
[TBL] [Abstract][Full Text] [Related]
71. Inhibition of miR-223 attenuates the NLRP3 inflammasome activation, fibrosis, and apoptosis in diabetic cardiomyopathy.
Xu D; Zhang X; Chen X; Yang S; Chen H
Life Sci; 2020 Sep; 256():117980. PubMed ID: 32561396
[TBL] [Abstract][Full Text] [Related]
72. New mechanism of lipotoxicity in diabetic cardiomyopathy: Deficiency of Endogenous H
Guo R; Wu Z; Jiang J; Liu C; Wu B; Li X; Li T; Mo H; He S; Li S; Yan H; Huang R; You Q; Wu K
Mech Ageing Dev; 2017 Mar; 162():46-52. PubMed ID: 27871808
[TBL] [Abstract][Full Text] [Related]
73. Long non-coding RNA MEG3 serves as a ceRNA for microRNA-145 to induce apoptosis of AC16 cardiomyocytes under high glucose condition.
Chen Y; Zhang Z; Zhu D; Zhao W; Li F
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31085717
[TBL] [Abstract][Full Text] [Related]
74. MicroRNA-495 Ameliorates Cardiac Microvascular Endothelial Cell Injury and Inflammatory Reaction by Suppressing the NLRP3 Inflammasome Signaling Pathway.
Zhou T; Xiang DK; Li SN; Yang LH; Gao LF; Feng C
Cell Physiol Biochem; 2018; 49(2):798-815. PubMed ID: 30165354
[TBL] [Abstract][Full Text] [Related]
75. Blockade of high mobility group box 1 involved in the protective of curcumin on myocardial injury in diabetes in vivo and in vitro.
Yan X; Xu P; Zhou L; Lu J; Tang H; Zheng Y; Cao H
IUBMB Life; 2020 May; 72(5):931-941. PubMed ID: 31909882
[TBL] [Abstract][Full Text] [Related]
76. MicroRNA-223 Regulates Cardiac Fibrosis After Myocardial Infarction by Targeting RASA1.
Liu X; Xu Y; Deng Y; Li H
Cell Physiol Biochem; 2018; 46(4):1439-1454. PubMed ID: 29689569
[TBL] [Abstract][Full Text] [Related]
77. MiR-30c/PGC-1β protects against diabetic cardiomyopathy via PPARα.
Yin Z; Zhao Y; He M; Li H; Fan J; Nie X; Yan M; Chen C; Wang DW
Cardiovasc Diabetol; 2019 Jan; 18(1):7. PubMed ID: 30635067
[TBL] [Abstract][Full Text] [Related]
78. Apocynin attenuates diabetic cardiomyopathy by suppressing ASK1-p38/JNK signaling.
Ding W; Feng H; Li WJ; Liao HH; Zhang N; Zhou ZY; Mou SQ; Lin Z; Xia-He NZ; Xia H; Tang QZ
Eur J Pharmacol; 2021 Oct; 909():174402. PubMed ID: 34348125
[TBL] [Abstract][Full Text] [Related]
79. Non-coding RNA involvement in the pathogenesis of diabetic cardiomyopathy.
Zhang W; Xu W; Feng Y; Zhou X
J Cell Mol Med; 2019 Sep; 23(9):5859-5867. PubMed ID: 31240820
[TBL] [Abstract][Full Text] [Related]
80. NLRP3 Inflammasome/Pyroptosis: A Key Driving Force in Diabetic Cardiomyopathy.
Zhang L; Ai C; Bai M; Niu J; Zhang Z
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142531
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
